Future efforts to more reliably and successfully treat this lethal breast cancer subtype will be built on the realization that the altered expression of STEAP3 in these individuals may have ramifications for overall survival and therapeutic strategies. This evidence concerns the gene STEAP3 and breast carcinoma.